EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular mechanism of secretory protein EFNA1 in HNSCC and its value in early screening

Yanan Fu, Mengqiao He, Jiayi Li, Jia Ji, Zhen Xiao, Yukun Ma, Xuelin Chen

Biochemical and Biophysical Research Communications · 2025

DOI: 10.1016/j.bbrc.2025.152243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2025. Verfasst von Yanan Fu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, The Third Affiliated Hospital of Qiqihar Medical University, China. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Biomarkers, Tumor, Early Detection of Cancer, Head and Neck Neoplasms. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Head and neck squamous cell carcinomas (HNSCC) is an aggressive malignancy, necessitating early diagnostic biomarkers. This study explores EFNA1's role in HNSCC and its potential for early screening. METHODS: Data from TCGA, CCLE, and Depmap databases were analyzed. Serum samples from HNSCC patients and controls were tested using ELISA. Cell proliferation, apoptosis assays, and KEGG pathway analysis were conducted. Western blotting assessed EphA2pS898, EphA2, and EFNA1's impact on the AKT/ERK1/2 pathway. RESULTS: EFNA1 expression was significantly higher in HNSCC tissues compared to healthy tissues (P < 0.05). ROC analysis showed an AUC of 0.924 for EFNA1 in predicting HNSCC, indicating its diagnostic potential. Serum EFNA1 levels were elevated pre-surgery and decreased post-surgery (P < 0.05), correlating with poor prognosis (P = 0.021). EFNA1 knockdown in BICR78 and SNU46 cells induced apoptosis (P < 0.05). EFNA1 overexpression increased proliferation, which was reversed by EFNA1 antibody. EFNA1 downregulated AKT/ERK1/2 pathway activity, with its interference preventing full pathway activation. CONCLUSION: EFNA1 is a promising biomarker for early HNSCC screening and a potential therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Squamous Cell Carcinoma of Head and NeckBiomarkers, TumorEarly Detection of CancerHead and Neck NeoplasmsEphrin-A1HumansApoptosisCell ProliferationCell Line, TumorMaleFemaleMiddle AgedPrognosisProto-Oncogene Proteins c-aktGene Expression Regulation, NeoplasticMAP Kinase Signaling System

Stichwörter der Autor:innen

EFNA1Early screeningHNCHead and neck cancerSquamous cell carcinoma

Substanzen

Biomarkers, TumorEphrin-A1Proto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Stomatology, The Third Affiliated Hospital of Qiqihar Medical University, China.
  • Department of Stomatology, Qiqihar Eye&ENT Hospital, China.
  • Department of Stomatology, The First Hospital of Qiqihar, China.
  • Medical Science Research Institute, Qiqihar Medical University, China.
  • Department of Stomatology, The Third Affiliated Hospital of Qiqihar Medical University, China. Electronic address: chenxuelin19892024@qmu.edu.cn.

Zitieren

APA

Fu, Y., He, M., Li, J., Ji, J., Xiao, Z., Ma, Y., & Chen, X. (2025). Molecular mechanism of secretory protein EFNA1 in HNSCC and its value in early screening. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2025.152243

Vancouver

Fu Y, He M, Li J, Ji J, Xiao Z, Ma Y, et al. Molecular mechanism of secretory protein EFNA1 in HNSCC and its value in early screening. Biochemical and Biophysical Research Communications. 2025. doi:10.1016/j.bbrc.2025.152243

BibTeX
@article{Fu2025,
  author = {Fu, Yanan and He, Mengqiao and Li, Jiayi and Ji, Jia and Xiao, Zhen and Ma, Yukun and Chen, Xuelin},
  title = {Molecular mechanism of secretory protein EFNA1 in HNSCC and its value in early screening},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2025},
  doi = {10.1016/j.bbrc.2025.152243}
}
Kostenlos starten →